Overview

LI-COR INC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering IRDYE 700DX CARBOXYLATE (DRUG SUBSTANCE INTERMEDIATE).

API / Drug Master Files

LI-COR INC holds 1 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • IRDYE 700DX CARBOXYLATE (DRUG SUBSTANCE INTERMEDIATE)Active2015-02-02
  • IRDYE 800CW CARBOXYLATEInactive2014-09-25
  • IRDYE 800CW NHS ESTER (DRUG SUBSTANCE INTERMEDIATE)Inactive2011-07-19

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LI-COR INC in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.